-
Mashup Score: 2
Next-generation sequencing has revealed the disruptive reality that advanced/metastatic cancers have complex and individually distinct genomic landscapes, necessitating a rethinking of treatment stra…
Categories: General Medicine News, Oncologists1Tweet
Improving outcomes for advanced & metastatic cancers requires a radical change in paradigm. This #OpenAccess review by @Dr_R_Kurzrock et al discusses transitioning from drug-centered strategies to patient-centered N-of-1 focus in #PrecisionMedicine trials. https://t.co/R62lxtsr89 https://t.co/u7Jxc57ZH6